In conclusion, this study demonstrated that UC supresses the progression of CRC via inhibiting the YBX1–AKT/mTOR signal axis (Fig. 7), which provided functional evidences for the application of UC in the treatment of CRC in clinical practice. The gene discussed is AKT1; the disease is colorectal carcinoma.